Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.020
-0.030 (-2.86%)
Aug 29, 2025, 4:00 PM - Market closed
Ocugen Market Cap
Ocugen has a market cap or net worth of $318.55 million as of August 29, 2025. Its market cap has decreased by -13.55% in one year.
Market Cap
318.55M
Enterprise Value
324.36M
1-Year Change
-13.55%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since December 3, 2014, Ocugen's market cap has increased from $126.80M to $318.55M, an increase of 151.22%. That is a compound annual growth rate of 8.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 298.20M | 27.16% |
| Dec 31, 2024 | 234.50M | 58.98% |
| Dec 29, 2023 | 147.50M | -48.17% |
| Dec 30, 2022 | 284.60M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.67% |
| Dec 31, 2020 | 296.50M | 3,472.29% |
| Dec 31, 2019 | 8.30M | 50.91% |
| Dec 31, 2018 | 5.50M | -88.84% |
| Dec 29, 2017 | 49.30M | 85.34% |
| Dec 30, 2016 | 26.60M | -42.80% |
| Dec 31, 2015 | 46.50M | -60.86% |
| Dec 31, 2014 | 118.80M | -6.31% |
| Dec 3, 2014 | 126.80M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.11B |
| Johnson & Johnson | 422.54B |
| AbbVie | 367.30B |
| UnitedHealth Group | 273.78B |
| Novo Nordisk | 249.15B |
| AstraZeneca | 247.25B |
| Novartis AG | 245.07B |
| Abbott Laboratories | 228.64B |